Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C .
Conclusion: Combination of sofosbuvir and simeprevir for 12 weeks resulted in.
94% sustained virological response-12 rates in patients with hepatitis C.
Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis .
Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4.
sofosbuvir in combination with ribavirin in HCV genotype 4 patients in Egypt.
Simeprevir in Combination with Sofosbuvir in Genotype, Janssen.
16 Nov 2015, Janssen Presents New Data Assessing OLYSIO, Simeprevir in Combination.
With Sofosbuvir in Genotype 4 Infected HCV Patients In Egypt.
FDA approves combination simeprevir and sofosbuvir for HCV .